Page last updated: 2024-08-17

triaziquone and Lymphangioendothelioma, Malignant

triaziquone has been researched along with Lymphangioendothelioma, Malignant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adler, S; Case, RW; Helm, F; Holtermann, OA; Klein, E; Milgrom, H; Murphy, GP; Prior, RL; Rosner, D; Stoll, HL	1

Reviews

1 review(s) available for triaziquone and Lymphangioendothelioma, Malignant

Article	Year
Immunologic approaches to the management of primary and secondary tumors involving the skin and soft tissues: review of a ten-year program. Transplantation proceedings, 1975, Volume: 7, Issue:2 Topics: Antigens, Bacterial; Antigens, Fungal; Antigens, Viral; Breast Neoplasms; Carcinoma, Basal Cell; Female; Humans; Hypersensitivity, Delayed; Immunotherapy; Lymphangiosarcoma; Lymphoma, Large B-Cell, Diffuse; Melanoma; Neoplasms, Multiple Primary; Nitrobenzenes; Precancerous Conditions; Skin Neoplasms; Skin Tests; Triaziquone; Vulvar Neoplasms	1975

Article

Year

Immunologic approaches to the management of primary and secondary tumors involving the skin and soft tissues: review of a ten-year program.

Transplantation proceedings, 1975, Volume: 7, Issue:2

Topics: Antigens, Bacterial; Antigens, Fungal; Antigens, Viral; Breast Neoplasms; Carcinoma, Basal Cell; Female; Humans; Hypersensitivity, Delayed; Immunotherapy; Lymphangiosarcoma; Lymphoma, Large B-Cell, Diffuse; Melanoma; Neoplasms, Multiple Primary; Nitrobenzenes; Precancerous Conditions; Skin Neoplasms; Skin Tests; Triaziquone; Vulvar Neoplasms

1975